Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Acute Myeloid Leukemia · Narcolepsy · JAZZ

Jazz Pharmaceuticals Ireland

Jazz Pharmaceuticals Ireland Limited

Jazz Pharmaceuticals Ireland patent portfolio — 36 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Waterloo Exchange, Waterloo Road, Dublin, 4, IE HQ
2003 Founded
3,631 Employees
Public company Type
JAZZ · NYSE Ticker
Company details
Status
Public
HQ
Waterloo Exchange, Waterloo Road, Dublin, 4, IE
Founded
2003
Employees
3,631
Programs
10
Drugs
72
Patents
36
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Jazz Pharmaceuticals Ireland patents

36 pharmaceutical patents indexed for Jazz Pharmaceuticals Ireland. 0 expire within 24 months.

Jazz Pharmaceuticals Ireland has 36 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

36 patents

Patent portfolio

  1. US 12396963

    Cannabidiol-type cannabinoid compound

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12383512

    Cannabidiol-type cannabinoid compound

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12364670

    Cannabidiol-type cannabinoid compound

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12263139

    Use of cannabidiol in the treatment of tuberous sclerosis complex

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12138233

    Methods of treating idiopathic hypersomnia

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12121571

    Recombinant L-asparaginase

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12102619

    Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12064399

    Use of cannabinoids in the treatment of epilepsy

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11986446

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11802279

    Modified L-asparaginase

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11571440

    Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11554102

    Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11426373

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11253494

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11160779

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11046946

    PEGylated L-asparaginase

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10959976

    Methods and compositions for treating excessive sleepiness

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10940133

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10912754

    Methods and compositions for treating excessive sleepiness

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10864181

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10675258

    Method of using gamma-hydroxybutyrate compositions for the treatment of disorders

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10512609

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10213400

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10195168

    Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10195151

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10174302

    Modified L-asparaginase

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9920311

    PEGylated L-asparaginase

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9486426

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9132107

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9050302

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8901173

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8772306

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8771735

    Immediate release dosage forms of sodium oxybate

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8716279

    Pharmaceutical compositions of clonazepam and method of use thereof

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8591922

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Jazz Pharmaceuticals Ireland have?

36 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Jazz Pharmaceuticals Ireland patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.